Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom J G Gevers

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
United European Gastroenterology Journal|May 2, 2023
Patient reported outcome measure thresholds: The next step in the management of polycystic liver diseaseRenée Duijzer, Tom J G Gevers
Current Opinion in Gastroenterology|December 31, 2010
Somatostatin analogues for treatment of polycystic liver diseaseTom J G Gevers, Joost P H Drenth
Nature Reviews. Gastroenterology & Hepatology|January 9, 2013
Diagnosis and management of polycystic liver diseaseTom J G Gevers, Joost P H Drenth
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2020
ReplySimon Pape, Tom J G Gevers, Joost P H Drenth
World Journal of Gastroenterology|June 27, 2013
Evaluation of hepatic cystic lesionsMarten A Lantinga, Tom J G Gevers, Joost P H Drenth
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2014
Diagnostic criteria in renal and hepatic cyst infectionMarten A Lantinga, Joost P H Drenth, Tom J G Gevers
Clinical Case Reports|August 4, 2025
Esophagitis Dissecans Superficialis in a Frail Older Patient: Questioning Its Benign NatureDonna Erven, Tom J G Gevers, Bart Spaetgens, et al.
Journal of Hepatology|April 10, 2024
The pathophysiology of polycystic liver diseaseRenée Duijzer, Melissa M Boerrigter, Tom J G Gevers, et al.
Journal of Hepatology|December 19, 2022
Reply to: "2022 international autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders"Romée J A L M Snijders, Tom J G Gevers, Joost P H Drenth
BMC Nephrology|April 6, 2012
Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney diseaseTom J G Gevers, Melissa Chrispijn, Jack F M Wetzels, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
United European Gastroenterology Journal|May 2, 2023
Patient reported outcome measure thresholds: The next step in the management of polycystic liver diseaseRenée Duijzer, Tom J G Gevers
Current Opinion in Gastroenterology|December 31, 2010
Somatostatin analogues for treatment of polycystic liver diseaseTom J G Gevers, Joost P H Drenth
Nature Reviews. Gastroenterology & Hepatology|January 9, 2013
Diagnosis and management of polycystic liver diseaseTom J G Gevers, Joost P H Drenth
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2020
ReplySimon Pape, Tom J G Gevers, Joost P H Drenth
World Journal of Gastroenterology|June 27, 2013
Evaluation of hepatic cystic lesionsMarten A Lantinga, Tom J G Gevers, Joost P H Drenth
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2014
Diagnostic criteria in renal and hepatic cyst infectionMarten A Lantinga, Joost P H Drenth, Tom J G Gevers
Clinical Case Reports|August 4, 2025
Esophagitis Dissecans Superficialis in a Frail Older Patient: Questioning Its Benign NatureDonna Erven, Tom J G Gevers, Bart Spaetgens, et al.
Journal of Hepatology|April 10, 2024
The pathophysiology of polycystic liver diseaseRenée Duijzer, Melissa M Boerrigter, Tom J G Gevers, et al.
Journal of Hepatology|December 19, 2022
Reply to: "2022 international autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders"Romée J A L M Snijders, Tom J G Gevers, Joost P H Drenth
BMC Nephrology|April 6, 2012
Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney diseaseTom J G Gevers, Melissa Chrispijn, Jack F M Wetzels, et al.
Pageof 7